Validation of International Working Group response criteria in higher‐risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium

The utility of the International Working Group (IWG) 2006 response criteria for myelodysplastic syndromes (MDS) as a surrogate endpoint for outcomes is unclear. We assessed the validity of the IWG 2006 response criteria in a large cohort of higher‐risk MDS patients (pts) treated at centers from the...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Med
Main Authors: Komrokji, Rami S., Al Ali, Najla H, Sallman, David, Padron, Eric, DeZern, Amy E., Barnard, John, Roboz, Gail J., Garcia‐Manero, Guillermo, List, Alan, Steensma, David P., Sekeres, Mikkael A.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2020
Teme:
Clinical Cancer Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7877342/
https://ncbi.nlm.nih.gov/pubmed/33350168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3608
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki